TTK Healthcare Ltd. Stock Falls to 52-Week Low of Rs.839

Stock Performance and Market Context

On 9 Mar 2026, TTK Healthcare Ltd. opened sharply lower with a gap down of -4.94%, touching an intraday low of Rs.839, which represents the lowest price level for the stock in the past year. This decline occurred in line with sector trends, as the broader Sensex index also experienced a negative session, falling by 1,862.15 points or -2.4% to trade at 77,028.67. The Sensex has been on a downward trajectory for three consecutive weeks, losing -6.99% over this period.

TTK Healthcare’s share price is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating sustained downward momentum. The stock’s 52-week high was Rs.1,402, highlighting a steep decline of approximately 40% from its peak.

Long-Term and Recent Financial Performance

Over the last year, TTK Healthcare has delivered a total return of -25.85%, significantly underperforming the Sensex, which gained 3.67% during the same period. The company’s performance has also lagged behind the BSE500 index over the last three years, one year, and three months, reflecting persistent challenges in generating shareholder value.

Financially, the company’s net sales have grown at a modest compound annual growth rate (CAGR) of 6.99% over the past five years, while operating profit has expanded at 15.42% annually. These growth rates are considered subdued relative to industry peers and broader market expectations for diversified sector companies.

Key Financial Metrics and Ratios

TTK Healthcare’s cash and cash equivalents stood at Rs.600.89 crores as of the half-year period, marking the lowest level recorded recently. The company’s debtors turnover ratio was 7.40 times, also at a low point, indicating slower collection efficiency. Notably, non-operating income accounted for 80.43% of the company’s profit before tax (PBT) in the latest quarter, suggesting a significant reliance on income sources outside core operations.

The company maintains a low average debt-to-equity ratio of zero, reflecting a conservative capital structure with minimal leverage. Return on equity (ROE) is reported at 6.5%, which, while positive, is modest for a company of its size and sector.

Valuation and Market Perception

TTK Healthcare trades at a price-to-book value of 1.1, which is considered attractive relative to its own historical valuations. However, the stock is priced at a premium compared to its peers’ average historical valuations, which may reflect market expectations or structural factors within the company’s business model.

The company’s price-to-earnings-to-growth (PEG) ratio stands at 7.6, indicating that the stock’s price is high relative to its earnings growth rate. Despite a 2.4% increase in profits over the past year, the elevated PEG ratio suggests limited earnings momentum relative to the current valuation.

Domestic mutual funds hold a negligible stake of just 0.01% in TTK Healthcare, which may imply limited institutional conviction or a cautious stance given the company’s recent performance and valuation metrics.

Sector and Market Environment

The diversified sector, in which TTK Healthcare operates, has experienced mixed performance amid broader market volatility. The India VIX index reached a new 52-week high on the same day, signalling increased market uncertainty and risk aversion among investors. The Sensex’s position below its 50-day moving average, despite the 50DMA remaining above the 200DMA, reflects a cautious market environment with potential for further volatility.

Summary of Rating and Market Grade

TTK Healthcare’s Mojo Score currently stands at 37.0, with a Mojo Grade of Sell, downgraded from Hold on 21 Jul 2025. The company’s market capitalisation grade is rated 4, reflecting its mid-cap status within the diversified sector. The downgrade in rating aligns with the stock’s recent price decline and the company’s subdued financial growth metrics.

The stock’s day change on 9 Mar 2026 was -0.86%, consistent with sector performance, but the broader trend remains negative given the new 52-week low and underperformance relative to benchmark indices.

Conclusion

TTK Healthcare Ltd.’s fall to Rs.839 marks a notable low point in its share price over the past year, driven by a combination of modest sales growth, limited profit expansion, and valuation concerns. The stock’s performance has lagged behind key market indices and sector peers, while financial ratios indicate challenges in operational efficiency and earnings momentum. Market conditions, including a weakening Sensex and heightened volatility, have compounded the stock’s downward pressure. Despite a conservative debt profile and an attractive price-to-book ratio, the company’s elevated PEG ratio and low institutional holding suggest cautious market sentiment.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today